JP2004517145A5 - - Google Patents

Download PDF

Info

Publication number
JP2004517145A5
JP2004517145A5 JP2002557935A JP2002557935A JP2004517145A5 JP 2004517145 A5 JP2004517145 A5 JP 2004517145A5 JP 2002557935 A JP2002557935 A JP 2002557935A JP 2002557935 A JP2002557935 A JP 2002557935A JP 2004517145 A5 JP2004517145 A5 JP 2004517145A5
Authority
JP
Japan
Prior art keywords
halogen
hydrogen
compounds
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002557935A
Other languages
English (en)
Japanese (ja)
Other versions
JP4417624B2 (ja
JP2004517145A (ja
Filing date
Publication date
Priority claimed from DE10102053A external-priority patent/DE10102053A1/de
Application filed filed Critical
Publication of JP2004517145A publication Critical patent/JP2004517145A/ja
Publication of JP2004517145A5 publication Critical patent/JP2004517145A5/ja
Application granted granted Critical
Publication of JP4417624B2 publication Critical patent/JP4417624B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002557935A 2001-01-17 2001-12-24 ピペラジニルカルボニルキノリンおよびイソキノリン Expired - Fee Related JP4417624B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10102053A DE10102053A1 (de) 2001-01-17 2001-01-17 Piperazinylcarbonylchinoline und -isochinoline
PCT/EP2001/015311 WO2002057256A1 (en) 2001-01-17 2001-12-24 Piperazinylcarbonylquinolines and -isoquinolines

Publications (3)

Publication Number Publication Date
JP2004517145A JP2004517145A (ja) 2004-06-10
JP2004517145A5 true JP2004517145A5 (enExample) 2009-06-18
JP4417624B2 JP4417624B2 (ja) 2010-02-17

Family

ID=7670921

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002557935A Expired - Fee Related JP4417624B2 (ja) 2001-01-17 2001-12-24 ピペラジニルカルボニルキノリンおよびイソキノリン

Country Status (22)

Country Link
US (1) US7329749B2 (enExample)
EP (1) EP1366039B1 (enExample)
JP (1) JP4417624B2 (enExample)
KR (1) KR100854481B1 (enExample)
CN (1) CN1249055C (enExample)
AR (1) AR035682A1 (enExample)
AT (1) ATE304010T1 (enExample)
BR (1) BR0116774A (enExample)
CA (1) CA2434773C (enExample)
CZ (1) CZ304144B6 (enExample)
DE (2) DE10102053A1 (enExample)
DK (1) DK1366039T3 (enExample)
ES (1) ES2248230T3 (enExample)
HU (1) HU230250B1 (enExample)
MX (1) MXPA03006360A (enExample)
MY (1) MY127293A (enExample)
PL (1) PL212087B1 (enExample)
RU (1) RU2280034C2 (enExample)
SI (1) SI1366039T1 (enExample)
SK (1) SK287333B6 (enExample)
WO (1) WO2002057256A1 (enExample)
ZA (1) ZA200306331B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0401300A3 (en) * 2001-01-18 2005-06-28 Merck Patent Gmbh Bifunctional fusion proteins with glucocerebrosidase activity
EP1997494A3 (en) * 2002-04-22 2009-06-10 Johns Hopkins University School of Medicine Modulators of hedgehog signaling pathways, compositions and uses related thereto
BR0312294A (pt) * 2002-06-29 2005-04-12 Zentaris Gmbh Arilcarbonil piperazinas e hteroarilcarbonilpiperazinas e o uso das mesmas para tratamento de doenças benignas e malignas
US20090311242A1 (en) * 2004-07-29 2009-12-17 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a)
GB2497476B (en) * 2010-09-06 2018-01-10 Guangzhou Inst Biomed & Health Amide Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
US4970714A (en) * 1989-01-05 1990-11-13 International Business Machines Corp. Adaptive data link protocol
ES2231992T3 (es) * 1997-07-07 2005-05-16 Kowa Co., Ltd. Derivados de diamina y composiciones farmaceuticas que los contienen.
EP1107758A2 (en) * 1998-08-28 2001-06-20 Scios Inc. Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
DE19934433A1 (de) * 1999-07-22 2001-01-25 Merck Patent Gmbh N-(Indolcarbonyl-)piperazinderivate

Similar Documents

Publication Publication Date Title
JP2004538039A5 (enExample)
JP2002532112A5 (enExample)
JP2003514758A5 (enExample)
JP2003520232A5 (enExample)
NO20041452L (no) 17-beta-hydroksysteroid-dehydrogenase type 3-inhibitorer for behandling av androgenavhengige sykdommer.
PT1204323E (pt) Fungicidas
JP2005510235A5 (enExample)
JP2005526058A5 (enExample)
JPH1133743A5 (enExample)
ATE303386T1 (de) Das citrat-salz des 5,8,14,- triazatetracyclo(10.3.1.02,11.04,9)-hexadeca- 2(11),3,5,7,9-pentaens
JP2003515534A5 (enExample)
NO20041200L (no) Fremgangsmate for fremstilling av citalopram.
JP2008501649A5 (enExample)
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
SE0100326D0 (sv) New compounds
JP2005528357A5 (enExample)
JP2006505391A5 (enExample)
SE9903290D0 (sv) Novel compounds
NO20031414L (no) Ny oksabispidinforbindelse som er nyttig i behandlingen av hjertearrytmier
JP2001354766A5 (enExample)
JP2004517145A5 (enExample)
JP2005536763A5 (enExample)
NO20000456D0 (no) Fremgangsmåte for fremstilling av 1,2-dikloretan
JP2003197278A5 (enExample)
JP2005513126A5 (enExample)